F. Guan, G. Villegas, J. Teichman, P. Mundel, A. Tufro 

Slides:



Advertisements
Similar presentations
Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
Advertisements

Nogo-p4 Suppresses TrkA Signaling Induced by Low Concentrations of Nerve Growth Factor Through NgR1 in Differentiated PC12 Cells Neurosignals 2016;24:25-39.
Volume 61, Issue 1, Pages (January 2002)
Volume 66, Issue 1, Pages (July 2004)
Induction of Podocyte VEGF164 Overexpression at Different Stages of Development Causes Congenital Nephrosis or Steroid-Resistant Nephrotic Syndrome  Delma.
Volume 75, Issue 6, Pages (March 2009)
Volume 82, Issue 7, Pages (October 2012)
Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria  Dan Wang, Chunsun Dai, Yingjian Li, Youhua.
Volume 66, Issue 1, Pages (July 2004)
Volume 63, Issue 3, Pages (March 2003)
Volume 61, Issue 1, Pages (January 2002)
Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells  W. Qi, X. Chen, S. Twigg, T.S. Polhill,
IL-2–mediated apoptosis of kidney tubular epithelial cells is regulated by the caspase-8 inhibitor c-FLIP  Caigan Du, Qiunong Guan, Ziqin Yin, Robert.
Fertility and Sterility
Darren J. Bridgewater, Jackie Ho, Victor Sauro, Douglas G. Matsell 
Volume 69, Issue 4, Pages (February 2006)
Volume 70, Issue 5, Pages (September 2006)
Volume 73, Issue 5, Pages (March 2008)
Mechanical stress reduces podocyte proliferation in vitro
PPAR-γ agonist protects podocytes from injury
C.B. Marshall, J.W. Pippin, R.D. Krofft, S.J. Shankland 
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 60, Issue 5, Pages (November 2001)
Volume 71, Issue 10, Pages (May 2007)
Volume 57, Issue 5, Pages (May 2000)
Volume 84, Issue 5, Pages (November 2013)
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Volume 72, Issue 4, Pages (August 2007)
Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis  Hua Liu, Radhakrishna Baliga  Kidney International 
Mechanisms of the proteinuria induced by Rho GTPases
Volume 67, Issue 4, Pages (April 2005)
Volume 68, Issue 1, Pages (July 2005)
Volume 64, Issue 5, Pages (November 2003)
Volume 66, Issue 4, Pages (October 2004)
Volume 78, Issue 2, Pages (July 2010)
Volume 77, Issue 11, Pages (June 2010)
Volume 73, Issue 8, Pages (April 2008)
Volume 84, Issue 2, Pages (August 2013)
Ephrin-B1 localizes at the slit diaphragm of the glomerular podocyte
Volume 67, Issue 3, Pages (March 2005)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Oliver Vonend, Clare M. Turner  Kidney International 
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Renoprotective role of the vitamin D receptor in diabetic nephropathy
Volume 69, Issue 2, Pages (January 2006)
Volume 69, Issue 9, Pages (May 2006)
Hai Tao Yuan, Su Ping Yang, Adrian Spencer Woolf  Kidney International 
Volume 67, Issue 1, Pages (January 2005)
Volume 66, Issue 1, Pages (July 2004)
Volume 64, Issue 4, Pages (October 2003)
Volume 62, Issue 5, Pages (November 2002)
Volume 65, Issue 1, Pages (January 2004)
Reverse transcriptase-polymerase chain reaction study of anion exchanger-2 in canine tissues and different Madin-Darby canine kidney cell types  Graham.
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 69, Issue 11, Pages (June 2006)
Volume 56, Issue 5, Pages (November 1999)
Keratinocyte G2/M Growth Arrest by 1,25-Dihydroxyvitamin D3 Is Caused by Cdc2 Phosphorylation Through Wee1 and Myt1 Regulation  Xiuju Dai, Kenshi Yamasaki,
Volume 70, Issue 5, Pages (September 2006)
Volume 63, Issue 6, Pages (June 2003)
Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells  S.-H. Wu, X.-H. Wu, C. Lu, L. Dong, G.-P.
R. Tapia, F. Guan, I. Gershin, J. Teichman, G. Villegas, A. Tufro 
Direct effects of dexamethasone on human podocytes
Volume 54, Pages S159-S161 (September 1998)
Volume 73, Issue 8, Pages (April 2008)
Volume 64, Issue 1, Pages (July 2003)
Volume 71, Issue 9, Pages (May 2007)
J. Martin, T. Bowen, R. Steadman  Kidney International 
IL-1β induces VEGF, independently of PGE2 induction, mainly through the PI3-K/mTOR pathway in renal mesangial cells  D. Solà-Villà, M. Camacho, R. Solà,
Volume 68, Issue 1, Pages (July 2005)
Presentation transcript:

Autocrine class 3 semaphorin system regulates slit diaphragm proteins and podocyte survival  F. Guan, G. Villegas, J. Teichman, P. Mundel, A. Tufro  Kidney International  Volume 69, Issue 9, Pages 1564-1569 (May 2006) DOI: 10.1038/sj.ki.5000313 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Immortalized murine podocytes. Morphology of cultured podocytes in undifferentiated and differentiated conditions. Simian virus 40 (SV40) large T antigen is expressed by undifferentiated podocytes, whereas the podocyte-specific marker, synaptopodin, is only expressed by differentiated podocytes. Kidney International 2006 69, 1564-1569DOI: (10.1038/sj.ki.5000313) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Expression of class 3 semaphorins and their receptors in podocytes: regulation by differentiation. (a) Semiquantitative reverse transcriptase (RT)-polymerase chain reaction (PCR) amplification showing sema 3A–3F detected in undifferentiated (33°C) and differentiated podocytes (37°C). Glutaraldehyde phosphate dehydrogenase (GAPDH) was amplified for loading control of each reaction. Primers used and PCR product sizes are indicated in Table 1. (b) Podocyte differentiation did not change class 3 semaphorin expression levels. Data are shown as mean±s.e.m., n=5. *P<0.05. (c) Reverse transcriptase-PCR amplification of neuropilin (NP)1, NP2, plexins A1, A2, A3 and D1 mRNAs from undifferentiated (33°C) and differentiated (37°C) podocytes. GAPDH was amplified for loading control of each reaction. Primers used and PCR product sizes are indicated in Table 1. (d) Quantification of RT-PCR, plexin A1, A2 and A3 increased 2–4-fold above control upon podocyte differentiation, n=4. *P<0.05. Kidney International 2006 69, 1564-1569DOI: (10.1038/sj.ki.5000313) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 3 Class 3 semaphorins and semaphorin receptor regulation by sema 3A in podocytes. Differentiated podocytes were grown in control conditions or exposed to rSema 3A (50 ng/ml) for 24 h. (a) Reverse transcriptase PCR amplification of class 3 semaphorins. Quantification of RT-PCR showing that only sema 3B mRNA was decreased to approximately 1/5 of control level, n=4. *P<0.05. (b) Reverse transcriptase-PCR amplification of plexins A1, A2, A3, B2, D1, NP1 and NP2. GAPDH was amplified for loading control of each reaction (not shown). Quantification of RT-PCR showing that plexins A1, A3 and D1 were decreased by 50%, whereas plexin A2 was not detected in podocytes exposed to sema 3A, n=4. *P<0.05. Kidney International 2006 69, 1564-1569DOI: (10.1038/sj.ki.5000313) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 4 Sema 3A induces podocyte apoptosis and decreases Akt phosphorylation. (a) Quantitation of podocyte apoptosis in control conditions and upon sema 3A exposure. Data are expressed as mean±s.e.m., n=4. *P<0.05. (b) Western blot showing phosphorylated Akt and total Akt podocyte levels in control conditions and after 15 min of sema 3A exposure, indicating that sema 3A decreases Akt phosphorylation, whereas total Akt remains unchanged. Kidney International 2006 69, 1564-1569DOI: (10.1038/sj.ki.5000313) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 5 Sema 3A regulates the expression of slit-diaphragm proteins in podocytes and isolated glomeruli. (a) Western blots showing time and dose response to sema 3A, demonstrating that sema 3A downregulates podocin expression. β-Actin Western blot is shown to document equal loading. (b) Western blots showing that sema 3A does not alter CD2-associated protein (CD2AP) expression (β-actin Western blot is shown to document equal loading) and co-immunoprecipitation showing that sema 3A decreases the association of podocin and CD2AP; podocin Western blot shows equal loading for immunoprecipitation. (c) Western blot showing that sema 3A slightly decreases nephrin expression at 4 h and increases nephrin expression by 15–20% at 12 and 24 h in isolated glomeruli. β-Actin is shown for loading control. (d) Co-immunoprecipitations showing that sema 3A decreases the association between podocin and nephrin, as well as podocin and CD2AP in isolated glomeruli; the corresponding podocin and CD2AP Western blots show equal loading of immunoprecipitates. Kidney International 2006 69, 1564-1569DOI: (10.1038/sj.ki.5000313) Copyright © 2006 International Society of Nephrology Terms and Conditions